Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:45 PM
Ignite Modification Date:
2025-12-24 @ 9:45 PM
NCT ID:
NCT07133932
Eligibility Criteria:
Inclusion Criteria:
* age ≥ 18 years old
* no gender restrictions
* patient diagnosed with acute cerebral infarction (within 30 days of onset) through cranial CT or MRI
* duration of mechanical ventilation ≥ 24 hours
* patient or their legal guardian agrees to participate in the study and signs an informed consent form
Exclusion Criteria:
* there are other significant conditions that affect diaphragm function, such as severe malnutrition, irreversible respiratory pump failure caused by medullary or cervical cord injury, and irreversible damage to the phrenic nerve
* significant agitation cannot be combined with transcutaneous electrical phrenic nerve stimulation
* severe skin damage or infection at the electrode placement site
* previous presence of severe lung disease (such as severe COPD, interstitial lung disease, pulmonary embolism, etc.), severe heart failure (NYHA Class IV)
* sepsis or shock requiring high-dose vasopressors
* the terminal state of the disease or expected survival period does not exceed 7 days
* pacemaker implantation
* pregnant or lactating women
* patients whose family members express their willingness to withdraw for treatment
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07133932
Study Brief:
Protocol Section:
NCT07133932